David S. Krause
- Infectious Diseases top 1%
- Epidemiology top 5%
- Parasitology top 1%
- Pharmacology top 10%
- Ecology, Evolution, Behavior and Systematics top 10%
- Co-authors
- Beth P. GoldsteinMichele WibleAnnette C. ReboliColeman RotsteinDeepali KumarDaniel H. KettThomas J. WalshRobert F. Betts
- Topics
- Pharmacogenetics and Drug Metabolism (7 papers)Antifungal resistance and susceptibility (3 papers)Vector-borne infectious diseases (2 papers)
- Journals
- New England Journal of MedicineClinical Infectious DiseasesAntimicrobial Agents and Chemotherapy
- Partner nations
- United StatesItalyCanada
In The Last Decade
David S. Krause
12 papers receiving 1.4k citations
Hit Papers
Peers
Comparison fields: 5 of 85
- Infectious Diseases 1.2k
- Epidemiology 757
- Parasitology 426
- Pharmacology 170
- Ecology, Evolution, Behavior and Systematics 127
Countries citing papers authored by David S. Krause
This map shows the geographic impact of David S. Krause's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David S. Krause with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David S. Krause more than expected).
Fields of papers citing papers by David S. Krause
This network shows the impact of papers produced by David S. Krause. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David S. Krause. The network helps show where David S. Krause may publish in the future.
Co-authorship network of co-authors of David S. Krause
This figure shows the co-authorship network connecting the top 25 collaborators of David S. Krause. A scholar is included among the top collaborators of David S. Krause based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David S. Krause. David S. Krause is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 3 | |
| 3 | 0 | |
| 4 | 2 | |
| 5 | 38 | |
| 6 | 4 | |
| 7 | 0 | |
| 8 | Anidulafungin versus Fluconazole for Invasive Candidiasisbreakdown → | 618 |
| 9 | 169 | |
| 10 | 129 | |
| 11 | Dalbavancin pharmacokinetics in subjects with mild or moderate hepatic impairment | 1 |
| 12 | Vaccination against Lyme Disease with RecombinantBorrelia burgdorferiOuter-Surface Lipoprotein A with Adjuvantbreakdown → | 509 |
| 13 | 10 | |
| 14 | 18 | |
| 15 | [Facilitation and safe-guarding of intestinal absorption of G-strophanthin with sodium lauryl sulfate]. | 2 |
About David S. Krause
David S. Krause is a scholar working on Pharmacology, Biological Psychiatry and Parasitology, having authored 15 papers that have together received 1.5k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (7 papers), Antifungal resistance and susceptibility (3 papers) and Vector-borne infectious diseases (2 papers). The work is most often cited by research in Infectious Diseases (1.2k citations), Parasitology (426 citations) and Applied Microbiology and Biotechnology (70 citations). David S. Krause has collaborated with scholars based in United States, Italy and Canada. Frequent co-authors include Beth P. Goldstein, Michele Wible, Annette C. Reboli, Coleman Rotstein, Deepali Kumar, Daniel H. Kett, Thomas J. Walsh, Robert F. Betts, Jennifer Schranz and Peter G. Pappas. Their work appears in journals such as New England Journal of Medicine, Clinical Infectious Diseases and Antimicrobial Agents and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.